Taken together, our study unravels a novel and as yet unrecognized detrimental role of TYK2 and IFNγ signaling in the immune defense against invasive cutaneous candidiasis and paves the way for exploring TYK2 inhibitors as potential treatment option. The gene discussed is TYK2; the disease is cutaneous candidiasis.